Access Genetics

Executive Summary

Access Genetics, operating through its OralDNA Labs division, is a U.S.-based personalized diagnostics company specializing in DNA-based testing and lab services. Founded in 2003 and headquartered in Eden Prairie, Minnesota, the company offers advanced molecular diagnostics for personalized medicine, with a focus on oral health and systemic disease risk assessment. Its PartnerLab program, supported by the TeleGene cloud platform, enables in-office and hospital labs to run tests efficiently. Despite being a private company with limited public financial or pipeline disclosures, Access Genetics holds a niche position in the growing precision diagnostics market. The company's long operating history and established laboratory infrastructure suggest a stable yet potentially undervalued entity. However, the absence of recent news or valuation data tempers conviction.

Upcoming Catalysts (preview)

• Q3 2026Expansion of OralDNA Testing Menu into New Disease Areas65% success
• Q4 2026Strategic Partnership with Major Dental or Medical Group50% success
• Q1 2027FDA Clearance for a Novel Saliva-Based Diagnostic Test40% success